Insiders · ONCO

Thomas Meier

Director at Onconetix, Inc. (ONCO) since February 2024

Thomas Meier has filed 3 insider reports with the SEC since February 2024, as director at Onconetix, Inc. (ONCO). The latest filing, on August 19, 2025, reports grant or award and other acquisition or disposition at Onconetix, Inc. (ONCO).

Filings
3
Companies
1
Bought on market
None
Sold on market
None

Companies where Thomas Meier is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Onconetix, Inc. logo
ONCO
Onconetix, Inc.
Directorsince February 2024657$2.89Aug 19, 2025

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Thomas Meier with

Other insiders at the same companies

Questions about Thomas Meier

What is Thomas Meier's role at Onconetix, Inc.?
Thomas Meier reports to the SEC as director at Onconetix, Inc. (ONCO), according to the latest filing on August 19, 2025.
How many shares does Thomas Meier own?
After the latest filing that states it, Thomas Meier directly owned 657 shares of Onconetix, Inc. (ONCO). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Thomas Meier bought or sold stock recently?
No open-market purchases or sales by Thomas Meier are on file. The filings report grant or award and other acquisition or disposition.
How do I get alerts when Thomas Meier files?
Follow Thomas Meier on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Thomas Meier (SEC CIK 0002010924). Totals count each trade once, skipping amendments whose original is on file, from Feb 16, 2024 on. View on SEC EDGAR · Get this as JSON